Peer-reviewed publications resulting from collaborative research projects.

  1. Characterisation and validation of Mel38; A multi-tissue microRNA signature of cutaneous melanoma.
  2. Design and multiseries validation of a web-based gene expression assay for predicting breast cancer recurrence and patient survival.
  3. Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix.
  4. Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors.
  5. An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin.
  6. Location of, immunogenicity of and relationships between neutralization epitopes on the attachment protein (G) of Hendra virus.
  7. Empirical array quality weights in the analysis of microarray data.
  8. Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.
  9. Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.
  10. Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary.
  11. Implementation of a novel microarray-based diagnostic test for cancer of unknown primary.
  12. Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung cancer.
  13. A plasma microRNA biomarker of melanoma as a personalised assessment of treatment response.
  14. Effect of ASCO/CAP guidelines for determining ER status on molecular subtype.
  15. Recreational Music-Making alters gene expression pathways in patients with coronary heart disease.
  16. BreastPRS is a gene expression assay that stratifies intermediate-risk Oncotype DX patients into high- or low-risk for disease recurrence.
  17. Intensive cardiovascular risk reduction induces sustainable changes in expression of genes and pathways important to vascular function.
  18. Gene expression differences in adipose tissue associated with breast tumorigenesis.
  19. Translating a gene expression signature for multiple myeloma prognosis into a robust high-throughput assay for clinical use.
  20. Importance of substantial weight loss for altering gene expression during cardiovascular lifestyle modification.
  21. Gene expression profiling during intensive cardiovascular lifestyle modification: Relationships with vascular function and weight loss.
  22. Development and validation of a plasma-based melanoma biomarker suitable for clinical use.
  23. Options available–from start to finish–for obtaining data from DNA microarrays II.